IMREG-1

Known as: IMREG 1 
A low molecular weight fraction of human leukocyte dialysates with potential immunostimulatory activity. IMREG-1 is shown to augment and accelerate… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1988-2015
01219882015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
A general method for the synthesis of dipeptides has been developed, which does not require any coupling reagents. This method is… (More)
Is this relevant?
1995
1995
IMREG-1, a low-molecular-weight immunomodulator derived from normal human leukocyte dialysates, has been shown to enhance… (More)
Is this relevant?
1991
1991
An immunomodulator, IMREG-1, derived from human leukocyte dialysates exerts a variety of effects on the cell-mediated immune… (More)
Is this relevant?
1991
1991
OBJECTIVE To determine if a 6-month course of therapy with IMREG-1, a leukocyte-derived immunomodulator, slows disease… (More)
Is this relevant?
1991
1991
IMREG-1, an immunomodulatory biological therapeutic, was studied in a placebo-controlled, double-blind, six-month trial in 45… (More)
Is this relevant?
1990
1990
Although considerable attention has been devoted to development of antiviral drugs for therapy of HIV infection, relatively… (More)
Is this relevant?
1988
1988
Human leukocyte dialysates contain substances capable of affecting human immune function. A low molecular weight subfraction… (More)
Is this relevant?